Jmri.sourceforge.net

Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 1 of 19 3 Bethesda Metro Suite 700 Bethesda MD 20814 [email protected] Telephone: 301-280-5925 OPPOSITION TO DEFENDANTS’
MATTHEW KATZER AND KAMIND
ASSOCIATES, INC.’S MOTION TO
DISMISS FOR MOOTNESS
OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 2 of 19 Because Jacobsen suffered injury in fact, caused by Defendants, and which can be redressed by a favorable result, this Court retains jurisdiction over the declaratory judgment relating to U.S. Patent No. 6,530,329, per Caraco Pharm. Labs., Ltd. v. Forest Labs, Inc., 527 F.3d 1278 (Fed. Cir. 2008). Defendants brought an anti-SLAPP motion in which they made false statements. Relying on these statements, this Court held Defendants’ activities were protected by the First Amendment, and thus protected by anti-SLAPP laws. This ruling left Jacobsen to wait until his declaratory judgment could be heard so that he could show Defendants’ statements were false. Only then could he move to vacate the anti-SLAPP ruling. In preparation for settlement talks, Jacobsen forced Defendants’ hand. He sought their positions on claim construction, infringement, validity, and enforceability. Defendants promised to provide them, and then after breaking their promise, were ordered to make the disclosures. Instead, Defendants filed a statutory disclaimer for the ‘329 patent, thus treating the ‘329 patent as if it never issued. Defendants then moved to dismiss the patent causes of action. However, under Caraco, the Court retains jurisdiction. The harm that Defendants caused through their anti-SLAPP motions can be redressed by the Court if it retains jurisdiction. Under Micron Tech., Inc. v. MOSAID Techs., Inc., 518 F.3d 897 (Fed. Cir. 2008), the Court has jurisdiction over all issued Katzer patents. Like MOSAID, Defendants engaged in aggressive enforcement tactics against all competitors, and had targeted Jacobsen next for suit. Defendants sent cease and desist letters and bills to his home and his employer. Defendants have accused Jacobsen of infringing multiple patents and represented the same to his employer and this Court. Because these facts closely follow the facts in Micron, in which the Federal Circuit found jurisdiction, this Court also has jurisdiction. The Court has jurisdiction over unenforceability of the ‘329 patent because Katzer asserted that Jacobsen infringed multiple patents. Inequitable conduct as to one patent may infect other related patents. Thus, the Court retains jurisdiction over this issue. Jacobsen is the prevailing party because he obtained a favorable result and has the necessary judicial imprimatur. Thus, the Court has jurisdiction to hear an attorney fee award. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 3 of 19 OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 4 of 19 Cases
Brooks Furniture Mfg., Inc. v. Dutailier Int’l, Inc., 393 F.3d 1378 (Fed. Cir. 2005) . 11
Buckhannon Board & Care Home, Inc. v. West Virginia Dep’t of Health & Human Resources, 532 Caraco Pharm. Labs., Ltd. v. Forest Labs, Inc., 527 F.3d 1278 (Fed. Cir. 2008) . 5, 7, 10 Carbonell v. I.N.S., 429 F.3d 894 (9th Cir. 2005). 14 Cat Tech LLC v. Tubemaster, Inc., 528 F.3d 871 (Fed. Cir. 2008) . 11 Flatley v. Mauro, 39 Cal. 4th 299 (2006) . 9 GP Indus. v. Eran Indus., 500 F.3d 1369 (Fed. Cir. 2007). 9 Highway Equipment Co. v. FECO, Ltd., 469 F.3d 1027 (Fed. Cir. 2006) . 14 Hynix Semiconductor Inc. v. Rambus Inc., 527 F. Supp. 2d 1084 (N.D. Cal. 2007) . 11 Inland Steel Co. v. LTV Steel Co., 364 F.3d 1318 (Fed. Cir. 2004). 14 Intel Corp. v. Via Techs., Inc., No. C 99-03062 WHA, 2001 WL 777085, (N.D. Cal. Mar. 20, Judin v. United States, 110 F.3d 780 (Fed. Cir. 1997) . 10 Judkins v. HT Window Fashion Corp., 529 F.3d 1334 (Fed. Cir. 2008) . 9 Lucent Techs., Inc. v. Gateway, Inc., __ F.3d __, No. 2007-1546, 2008 WL 4349236 (Fed. Cir. Lucent Techs., Inc. v. Gateway, Inc., 525 F.3d 1200 (Fed. Cir. 2008) . 11 MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) . 11, 12, 13 Micron Tech., Inc. v. MOSAID Techs., Inc., 518 F.3d 897 (Fed. Cir. 2008). 11, 12, 15 Monsanto Co. v. Bayer Bioscience, N.V., 514 F.3d 1229 (Fed. Cir. 2008). 11 Nilssen v. Osram Sylvania, Inc., 504 F.3d 1223 (Fed. Cir. 2007) . 11 Peters v. Active Mfg. Co., 129 U.S. 530 (1889) . 8 Plumtree Software, Inc. v. Datamize, LLC, 473 F.3d 1152 (Fed. Cir. 2006) . 13 Prasco, LLC v. Medicis Pharm. Corp., 537 F.3d 1329 (Fed. Cir. 2008). 11 Samsung Elecs. Co. v. Rambus Inc., 440 F. Supp. 2d 495 (E.D. Va. 2006). 14 Samsung Elecs. Co. v. Rambus, Inc., 523 F.3d 1374 (Fed. Cir. 2008) . 10 SmithKline Beecham Corp. v. Apotex Corp., 439 F.3d 1312 (Fed. Cir. 2006) . 8 Steel Co. v. Citizens for a Better Env’t, 523 U.S. 83 (1998) . 6 Teva Pharms. USA, Inc. v. Novartis Pharms. Corp., 482 F.3d 1330 (Fed. Cir. 2007) . 11 TruePosition, Inc. v. Allen Telecom, Inc., No. C.A. 01-823 GMS, 2003 WL 151227 (D. Del. Jan. Statutes
OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 5 of 19 Jacobsen respectfully submits this Opposition to Defendants’ Motion to Dismiss his causes of action for declaratory judgment relating to U.S. Patent No. 6,530,329 (“the ‘329 patent”). STATEMENT OF ISSUES
1. Does the Court retain jurisdiction over the declaratory judgment causes of action relating to the ‘329 patent because of harm arising from false statements that Defendants and Kevin Russell 2. Does Defendants’ pattern of accusations that Jacobsen infringed multiple patents, combined with their aggressive litigation tactics, their representations to this Court, and their history of suing competitors, support declaratory judgment jurisdiction over all Katzer patents? 3. Does the Court retain jurisdiction over the declaratory judgment cause of action relating to unenforceability of the ‘329 patent because of Defendants’ accusations that Jacobsen infringed 4. Because Jacobsen prevailed in making the ‘329 patent unenforceable, does the Court retain jurisdiction over a future attorney fee motion? RELEVANT FACTS
Three and a half years ago, Defendants sent the first of multiple cease and desist letters to Jacobsen’s home address, alleging infringement of U.S. Patent No. 6,530,329. Declaration of Robert Jacobsen [hereinafter Jacobsen Decl.] ¶ 1, Ex. A. Later, they included invoices in excess of $200,000 to Jacobsen’s home address, and charged him with 7,000 infringements. Id. ¶ 3, 4, 6, 7, Ex. C, D, G. They initially offered a license of $19/copy. Id. Ex. A. They increased the license to $29/copy, implying that they had decided to charge him with infringement of other patents beside the ‘329 patent. Id. Ex. C. In October 2005, they sent a FOIA request, which included unnecessary allegations of patent infringement, an invoice for more than $200,000, and a false claim that a federal lawsuit had been filed against Jacobsen, to Jacobsen’s employer, the U.S. Department of Energy and Lawrence Berkeley National Laboratory. Id. ¶ 5, Ex. E at 1, 3, 18. In the FOIA request, Defendants charged Jacobsen with infringement of not only the ‘329 patent, but of multiple unspecified patents. Id. Ex. E at 1 (FOIA request: “KAMIND Associates, Inc. is a small software vendor that has patents being infringed by the JMRI project sponsored by the OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 6 of 19 This wasn’t the first time Defendants had made infringement allegations against a competitor. In September 2002, Defendants, through their counsel Kevin Russell, charged DigiToys and Freiwald Software with patent infringement. Request for Judicial Notice Exs. I & J. Russell wrote both DigiToys and Freiwald Software, charging them with infringing 2 claims from 2 patents, but filed suit against both competitors, alleging infringement of all 342 claims from all then-issued patents. Id. Exs. I, J, K, & L. Defendants backed down after both competitors challenged Defendants with inequitable conduct. See Second Amended Complaint [“SAC”] [Docket #191] ¶ 95. But Defendants soon found an easier target—Glenn Butcher—and through the similar intimidation tactics, forced him to comply with their terms. See Jacobsen Decl. Ex. J. Meanwhile, Defendants boasted about their patent portfolio and that they aggressively pursued enforcement. Id. Ex. K & L. After DigiToys and Freiwald Software, Jacobsen was Defendants’ After Defendants’ first letter, Jacobsen challenged Defendants to provide proof of their allegations against him. Id. ¶ 2. Defendants did not even produce a claim construction position. See id. ¶¶ 1, 3, 4, 6, 7, 9, Ex. A, C, D, G, I. After repeated accusations, the FOIA request, and Defendants’ pattern of enforcement, Jacobsen filed this lawsuit in March 2006. The core of the lawsuit was the declaratory judgment causes of action of non-infringement, invalidity, and After Jacobsen filed his Complaint, Defendants Matthew Katzer and KAMIND Associates, and then-Defendant Kevin Russell, filed anti-SLAPP motions in mid-May 2006. In affidavits to these motions, Katzer and Russell continued to assert that Jacobsen and JMRI infringed multiple Katzer patents. Declaration of Matthew Katzer in Support of Special Motion to Strike [Docket #13] [hereinafter Katzer anti-SLAPP Decl.] ¶ 5 (“…infringing KAM’s patents.”), ¶ 7 (“…infringement of KAM’s patents.”); Defendants’ Matthew Katzer and KAMIND Associates, Defendants Matthew Katzer and KAMIND Associates, Inc.’s Special Motion to Strike Plaintiff’s Libel Claim Under Cal. Civ. Proc. Code § 425.16 [Docket #12]; Special Motion to Strike Plaintiff’s Claims Against Kevin Russell Under Cal. Civ. Proc. Code § 425.16 [Docket #23]. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 7 of 19 Inc. Special Motion to Strike Plaintiff’s Libel Claim under Cal. Civ. Pro. Code § 425.16 [Docket #29] at 5, l. 7 (“KAM believes that certain JMRI software infringes on KAM patents.”), at 8, ll. 21- 22 (“…to alert the DOE that the JMRI project was infringing on KAM patents.”) (emphasis added in all). Katzer and Russell also stated their FOIA request was sent in preparation for a lawsuit, contemplated in good faith, for infringement of the Katzer patents. Katzer anti-SLAPP Decl. at 3; Declaration of Kevin Russell in Support of Special Motion to Strike [Docket # 23] [hereinafter Jacobsen strenuously objected to Katzer and Russell’s statements that any lawsuit was contemplated in good faith. In his June 9, 2006 Opposition, Jacobsen sought to show that Katzer and Russell acted in bad faith. He provided evidence supporting the patent declaratory judgment causes of actions to show that Defendants and Russell engaged in sham litigation and Walker Process fraud. On July 21, 2006, he sent Rule 11 letters to Katzer’s counsel, Scott Jerger, and Russell’s counsel, David Zeff, charging them with knowingly procuring a fraud upon the court. Declaration of Victoria Hall Exs. A& B. Mr. Zeff responded. Id. Ex. C. However, the earliest Jacobsen could file the Rule 11 motions was August 12, 2006. At the August 11, 2006 hearing, the Court ruled in favor of Defendants and then-Defendant Russell. In its October 20, 2006 order, the Court looked to Katzer and Russell’s declarations to determine if they had made a prima facie case, but did not address the issues that Jacobsen raised. See Order Granting Defendants’ Motions to Dismiss and Special Motions to Strike [Docket #111] 2 Memorandum in Opposition to Defendants Matthew Katzer and KAMIND Associates, Inc.’s Special Motion to Strike Plaintiff’s Libel Claim [Docket # 49] at 10-14; Memorandum in Opposition to Defendant Russell Motion to Strike Claims 5 and 7 [Docket # 45] at 9-12; Declaration of Robert Jacobsen in Support of Opposition to Defendants Matthew Katzer and KAMIND Associates, Inc.’s Special Motion to Strike Plaintiff’s Libel Claim [Docket # 46], at 15-26, Exs. W-BB. Declaration of Robert Jacobsen in Support of Opposition to Defendant Russell Motion to Strike Claims 5 and 7 [Docket # 51] at 15-26, Exs. W-BB; Declaration of Hans Tanner in Support of Opposition to Defendants Matthew Katzer and KAMIND Associates, Inc.’s Special Motion to Strike Plaintiff’s Libel Claim [Docket #] at 3-5, Exs. F-G; Declaration of Hans Tanner in Support of Opposition to Defendant Russell Motion to Strike Claims 5 and 7 [Docket #] at 3-5, Exs. F-G. Kevin Russell, acting on Katzer’s behalf, sent these references to patent examiners, who began issuing rejections of all pending patent claims, based in part on Jacobsen’s anti-SLAPP evidence. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 8 of 19 at 11 n.3. Thus, Jacobsen was not permitted to challenge the veracity of statements in Katzer and Russell’s anti-SLAPP affidavits. The Court saw these issues as relating to the merits of the causes of action challenged under anti-SLAPP, and deferred the issues as they related to declaratory A year later, in preparation for settlement talks, Jacobsen sought the basis for Katzer and Russell’s purported good faith basis for believing that Jacobsen infringed Katzer patents. See Order re: Settlement Conference [Docket #199], at 1. Judge Laporte agreed that Jacobsen should have this information, and in late October 2007, Katzer agreed to provide disclosures on claim construction, infringement, validity, and enforceability of claim 1 of the ‘329 patent. See id. Three months passed while Jacobsen waited for the information, but Katzer did not disclose it. See id. Jacobsen sought Judge Laporte’s assistance to get the information, and Judge Laporte again ordered to Katzer to disclose it. See id. Judge Laporte gave Defendants until January 31, 2008 to produce the disclosures. Defendants violated the order. Jacobsen protested and sought sanctions. Suddenly and without explanation, Defendants filed a disclaimer the next day, February 1, 2008, rather than produce the disclosures. See Declaration of Matthew Katzer [Docket #203], Ex. A. Then, Defendants moved to dismiss Jacobsen’s declaratory judgment causes of action. Defendants still have not produced the disclosures to Jacobsen. As late as April 4, 2008, Katzer was charging Jacobsen with infringement of at least one enforceable patent. See Joint Case Management Statement [Docket # 216] at 2. At the April 11, 2008 hearing, Katzer made self-serving assertions that he disclaimed the ‘329 patent solely for economic reasons, without providing an explanation While these events unfolded, Hans Tanner, who Katzer had sued in 2002, shut down DigiToys in March 2008 because of the threats that the Katzer patents posed to his company. See Request for Judicial Notice Ex. A. Also, after withholding one examiner’s rejections from other examiners, Russell submitted the rejections but buried them in 2000 pages of otherwise irrelevant material. See id. Ex. B (Information Disclosure Sheet for U.S. Patent App. No. 11/607,233). 4 Plaintiff objects to Defendants’ general explanation of “economic reasons” without a statement from Defendants on the record detailing what all those reasons are. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 9 of 19 Nonetheless, examiners at the Patent Office continued to issue rejections that bar patentability of all pending claims in Katzer patent applications. The rejections are the result of Katzer and Russell’s submitting the evidence that Jacobsen put forward in his anti-SLAPP declaration. See, e.g. id. Ex. C (January 2007 Information Disclosure Sheet for U.S. Patent App. No. 11/592,784) at 11-13; Ex. D (Office Action dated Apr. 3, 2008, rejecting all pending claims); Ex. E (June 2006 Information Disclosure Sheet for U.S. Patent App. No. 10/889,995) at 4-7; Ex. F (Office Action dated Aug. 7, 2006, rejecting all pending claims); Ex. G (Office Action dated Dec. 21, 2006, rejecting all pending claims). Katzer has failed to address these rejections, and is instead ARGUMENT
Jacobsen’s Declaratory Judgment Causes of Action Remain Live Controversies
Defendants’ disclaimer does not automatically moot the declaratory judgment causes of action for non-infringement, invalidity, and unenforceability of the ‘329 patent. The Federal Circuit recently held, in a similar situation, that a unilateral covenant not to sue did not moot declaratory judgment. Caraco Pharm. Labs., Ltd. v. Forest Labs, Inc., 527 F.3d 1278 (Fed. Cir. 2008). Similar reasoning supports declaratory judgment jurisdiction here. In Caraco Pharm., a generic manufacturer, Ivax, filed an abbreviated new drug application (ANDA) to manufacture a generic version of Lexapro®, a drug used to treat depression and anxiety disorders. Id. at 1286. Forest is Lexapro®’s manufacturer. Id. In filing the ANDA, Ivax certified that Forest’s two patents were invalid or would not be infringed. Id. at 1282-83, 1286. As the first to file the ANDA, Ivax would have a 180-day exclusivity period from either (1) the start of commercial marketing or (2) the date of a court judgment in its favor. During this period, no other generic pharmaceutical companies could manufacture the drug. See id. at 1283. However, once the exclusivity period ended, subsequent generic companies could file ANDAs and seek to manufacture the drug. Id. at 1284. Subsequent generic companies could begin manufacturing the drug only after obtaining a court judgment in their favor. Id. When Ivax filed its ANDA, the ANDA constituted a technical act of infringement, per the statute. Id. at 1286. Forest brought a patent infringement suit against Ivax on one of the two Forest OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 10 of 19 patents, and eventually prevailed. Id. Caraco then filed an ANDA to manufacture a generic Lexapro®. Id. at 1288. Forest brought suit against Caraco for infringement of one of the two patents. Id. Caraco sought declaratory judgment of non-infringement on the second patent, but Forest sought to dismiss, arguing no case or controversy existed. Id. If Caraco obtained a court judgment, then Caraco would trigger the beginning of the Ivax’s 180-day exclusivity period. Id. at 1287-88. After the exclusivity period ended, then Caraco could begin its manufacture. See id. at 1287. Instead of litigating the second patent, Forest unilaterally granted Caraco a covenant not to sue, and the district court dismissed Caraco’s declaratory judgment cause of action for lack of The Federal Circuit reversed, holding that Forest’s covenant not to sue did not cause the district court to lose jurisdiction over Caraco’s declaratory judgment cause of action. See id. at 1291, 1297. Caraco had standing because, without a declaratory judgment decree, it faced the inability to start its generic manufacture. The Court found the issues were ripe for judicial review. The matter was not moot because a live controversy existed as to whether Caraco could be entitled to a court judgment to trigger its generic manufacture start date. Id. at 1291-97. Applying Caraco here shows that Jacobsen has standing, the matter is ripe for judicial review, and is not moot. This Court has jurisdiction. Jacobsen Has Standing to Maintain the Declaratory Judgment Causes of Action Jacobsen has standing for the declaratory judgment causes of action because he suffered injury-in-fact, caused by Defendants and their counsel Kevin Russell, which would be redressed if the Court retained jurisdiction over these causes of action. The Supreme Court has explained that the “irreducible constitutional minimum of standing” contains the following three requirements: First and foremost, there must be alleged (and ultimately proved) an “injury in fact”—a harm suffered by the plaintiff that is “concrete” and actual or imminent, not “conjectural” or “hypothetical.” Second, there must be causation—a fairly traceable connection between the plaintiff's injury and the complained-of conduct of the defendant. And third, there must be redressability—a likelihood that the requested Steel Co. v. Citizens for a Better Env’t, 523 U.S. 83, 102-03 (1998) (internal citations omitted). OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 11 of 19 Caraco, 527 F.3d at 1291. Jacobsen suffered injury-in-fact when Defendants and Kevin Russell prevailed in their anti-SLAPP motions and affidavits, requiring Jacobsen to pay more than $30,000 Defendants and Kevin Russell caused the injury because they made false statements in their declarations that they acted on a good faith belief that Jacobsen was engaging in patent infringement. Had they told the truth in their declarations, Defendants and Mr. Russell would have (a) they never knew of one instance of patent infringement, let alone 7,000 infringements, that Jacobsen was purportedly responsible for. Their “voluntary” disclaimers, made the day after Judge Laporte’s deadline to provide patent disclosures, and their continued inability to provide any claim construction position or infringement position, show that Katzer and Russell made allegations of infringement in bad faith. Furthermore, because Jacobsen challenged Katzer and Russell’s attorneys with Rule 11 letters, Katzer and Russell’s attorneys had a duty to confirm the basis for their client’s purported good faith belief of Jacobsen’s infringement. (b) they had withheld material references with the intention to deceive patent examiners, and they had succeeded in their deception. Most, if not all, references they eventually produced to the Patent Office were in their possession when they prosecuted the application that became the ‘329 patent. Once patent examiners learned of the additional prior art, in part due to Jacobsen’s evidence in his anti-SLAPP declaration, the examiners began issuing rejections barring all pending patent claims. Katzer and Russell have been unable to overcome these rejections, and are (c) they represented to patent examiners that Katzer’s claims were an advance over prior art DigiToys, when they later implicitly admitted through the lawsuit against DigiToys that DigiToys anticipated or made obvious the Katzer claims. This is because the accused method in DigiToys 5 Under Jacobsen’s claim construction, described in the Second Amended Complaint ¶¶ 17-21, he does not infringe. Claim 1 of the ‘329 patent requires three computers to perform the claimed method. See id. ¶¶ 388-390, 412-413. JMRI software is normally used on one computer. Id. ¶ 398. Jacobsen knows no one who has used three computers to run JMRI. Id. ¶ 387, 422. Defendants have never identified anyone who has used three computers, although Defendants monitor email postings relating to JMRI usage. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 12 of 19 software was disclosed in a publication that was distributed with DigiToys, prior to the filing date of Katzer’s first patent application. That which infringes if later, anticipates in earlier. Peters v. Active Mfg. Co., 129 U.S. 530, 537 (1889); SmithKline Beecham Corp. v. Apotex Corp., 439 F.3d 1312, 1321 (Fed. Cir. 2006). Katzer and Russell never told examiners any details about DigiToys until Jacobsen filed suit. The patent examiners’ recent rejections citing DigiToys also show that Katzer’s claims were not advances over DigiToys. (d) they knew that Jacobsen used his work email address for the occasional (1-2 emails/day) posts to JMRI listservs, just like Mr. Katzer used to use his Intel Corp. work email address to post to model train listservs. Katzer communicated multiple times with Jacobsen through Jacobsen’s work email address, and knew Jacobsen was a professor at UC Berkeley and a physicist at (e) they knew from the time of JMRI’s formation that JMRI consisted of a group of hobbyists, and was not sponsored or connected in any way to the U.S. Department of Energy or the Lawrence Berkeley National Laboratory. Katzer had known Jacobsen personally for several years through Katzer’s involvement with the NMRA Digital Command Control Working Group. Katzer has no evidence that JMRI was ever sponsored by DOE. (f) Katzer never saw any banner indicating government sponsorship because there never (g) the studies by Roger Webster—studies which Katzer cited in his anti-SLAPP declaration as a basis for his belief that the U.S. Department of Energy was sponsoring JMRI— were funded not by the U.S. Department of Energy but by the National Science Foundation as educational grants in 1993 and 1996, more than 1 year before Katzer filed his first patent application. The National Science Foundation has nothing to do with the Department of Energy and the Berkeley Lab. Furthermore, Dr. Webster’s work disclosed that undergraduate students were developing software for client-server networking for model train layouts by 1993, which Katzer in 1998 claimed as the first to invent. Katzer did not disclose Dr. Webster’s work to patent examiners until after Jacobsen filed suit. Thus, Jacobsen’s harm was caused when Katzer and Russell made false statements in their OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 13 of 19 Finally, the harm from Defendants’ and Russell’s false affidavits can be redressed by retaining jurisdiction on the declaratory judgment causes of action. “…[If] the defendant concedes, or the evidence conclusively establishes, that the assertedly protected speech or petition activity was illegal as a matter of law, the defendant is precluded from using the anti-SLAPP statute to strike the plaintiff’s action.” Flatley v. Mauro, 39 Cal. 4th 299, 320 (2006). If Defendants and Russell had told the truth, they would not be entitled to claim their activities were protected because they did not have a subjective good faith belief that Jacobsen infringed a valid and enforceable patent, and because no reasonable person would have a good faith belief that Jacobsen infringed a valid and enforceable patent. Thus, their activities amount to sham litigation or Walker Process fraud, neither of which is protected by the First Amendment. See Judkins v. HT Window Fashion Corp., 529 F.3d 1334, 1338-39 (Fed. Cir. 2008); GP Indus. v. Eran Indus., 500 F.3d 1369, 1374-75 (Fed. Cir. 2007). Jacobsen has standing. Jacobsen’s Declaratory Judgment Causes of Action Are Ripe for Judicial Determination Because the issues are fit for judicial determination and because Jacobsen would suffer hardship if the court withheld consideration, the declaratory judgment causes of action are ripe. See Caraco Pharm. Labs., Ltd. v. Forest Labs, Inc., 527 F.3d 1278, 1294-95 (Fed. Cir. 2008). Here, declaratory judgment jurisdiction is based on events that have occurred which inflicted significant harm on Jacobsen. This supports ripeness. Cf. Ohio Forestry Ass’n, Inc. v. Sierra Club, 523 U.S. 726, 732-36 (1998). Defendants and Russell charged Jacobsen with infringement, and relied on that charge of purported infringement as a basis for their anti-SLAPP motions. When ordered to show proof of that infringement, Defendants and Russell could not even put forward one example of infringement, let alone 7,000 infringements, that Jacobsen was purportedly responsible for. Nor could they defend against Jacobsen’s charges of invalidity and 6 Jacobsen does not seek reconsideration of anti-SLAPP at this time. He will await Defendants’ disclosures on claim construction, infringement, validity, and enforceability before making a decision on his next step. Jacobsen may then file a motion to vacate or a motion for reconsideration the anti-SLAPP ruling. To move the case closer to settlement, Jacobsen recommends that the Court enforce Judge Laporte’s order requiring the disclosures on claim construction, infringement, validity, and enforceability. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 14 of 19 unenforceability. They could not even offer a claim construction, which the foundation for a good faith belief of infringement. See Judin v. United States, 110 F.3d 780, 784 (Fed. Cir. 1997). Instead, Defendants, through Russell, disclaimed the ‘329 patent and then moved to dismiss the declaratory judgment causes of action. Thus, the issues are in sharp focus and fit for judicial Jacobsen will suffer hardship if the Court withholds consideration, because Jacobsen paid more than $30,000 in attorneys fees that, had Defendants and Russell told the truth, would never have been granted. Unless the court retains jurisdiction, Jacobsen may be denied his due process right to challenge Defendants’ and Russell’s assertions. Thus, the matter is ripe for determination. Dispute over Defendants’ Anti-SLAPP Motions and Affidavits Keeps Controversy Alive The declaratory judgment causes of action are not moot because Jacobsen has a personal stake in the outcome—he may seek the return of the attorney fee awards paid to Defendants and their counsel and obtain his own attorney fees and costs. A personal stake in the outcome is necessary at the outset and throughout the litigation. See Caraco, 527 F.3d at 1296. Jacobsen strongly disputed, and continues to dispute, that Defendants and Russell had a good faith belief that Jacobsen was engaging in infringement. The Court accepted Katzer and Russell’s statements as true to determine if they had made a prima facie case, which left Jacobsen to wait until discovery and summary judgment on the declaratory judgment causes of action before he could move to vacate for fraud on the Court. Because a controversy exists over whether Defendants’ and Russell’s activities were protected under the First Amendment, which can be resolved only through the declaratory judgment causes of action, these causes of action are not made moot by the patent disclaimer. The matter can become moot only when the Court resolves the matter, or when Katzer and Russell vacate the anti-SLAPP ruling, return the court award plus interest, and pay Jacobsen’s fees and costs. Samsung Elecs. Co. v. Rambus, Inc., 523 F.3d 1374, 1379 (Fed. Cir. 2008). Thus, the Court retains jurisdiction over the declaratory judgment causes of action. 7 The second prong of the Federal Circuit’s previous declaratory judgment test is now determined by analyzing whether the dispute is real and immediate, which is related to the standing analysis. For potentially infringing products, the Federal Circuit considers whether the declaratory plaintiff is engaging in potentially infringing activities, or has taken concrete steps to do so. Prasco, LLC v. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 15 of 19 Jurisdiction Exists Over Declaratory Judgment for the ‘329 Patent
Due to the allegation that Jacobsen infringed multiple patents, the declaratory judgment action relating to unenforceability of the ‘329 patent is not moot. Inequitable conduct as to one patent may infect other related patents, making them unenforceable. Nilssen v. Osram Sylvania, Inc., 504 F.3d 1223, 1230 (Fed. Cir. 2007). Also, the Court retains jurisdiction over the declaratory judgment cause of action relating to unenforceability so that it may determine an attorney fee award. Monsanto Co. v. Bayer Bioscience, N.V., 514 F.3d 1229, 1242-44 (Fed. Cir. 2008); see Brooks Furniture Mfg., Inc. v. Dutailier Int’l, Inc., 393 F.3d 1378, 1381 (Fed. Cir. 2005). Thus, the Court has a separate basis for denying Defendants’ motion to dismiss for mootness the declaratory judgment cause of action for unenforceability of the ‘329 patent. This Court Has Jurisdiction Over Multiple Katzer Patents
According to a new interpretation of the declaratory judgment standard, as stated in Micron Tech., Inc. v. MOSAID Techs., Inc., 518 F.3d 897, 898-902 (Fed. Cir. 2008), this Court has jurisdiction over declaratory judgment causes of action relating to other Katzer patents. The Micron decision is one of several that the Federal Circuit issued after the Supreme Court broadened declaratory judgment jurisdiction in MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007). Medicis Pharm. Corp., 537 F.3d 1329, 1336 n. 4 (Fed. Cir. 2008); Cat Tech LLC v. Tubemaster, Inc., 528 F.3d 871, 880 (Fed. Cir. 2008). However, when method patents are involved, as they are here, a product which may be, but is not necessarily, used for infringement can support declaratory judgment. E.g., Lucent Techs., Inc. v. Gateway, Inc., __ F.3d __, No. 2007-1546, 2008 WL 4349236 (Fed. Cir. Sept. 25, 2008), at *3; Lucent Techs., Inc. v. Gateway, Inc., 525 F.3d 1200, 1203-04 (Fed. Cir. 2008) (intervenor Microsoft obtaining, and the Federal Circuit affirming, declaratory judgment for non-infringement of method claim). This is especially true when bad faith scare tactics as those used by Katzer and Russell are employed. See Cat Tech, 528 F.3d at 878 (describing the purpose of the Declaratory Judgment Act as to allow declaratory plaintiffs, who were victimized by their competitors’ scare tactics, to seek declaratory relief); Teva Pharms. USA, Inc. v. Novartis Pharms. Corp., 482 F.3d 1330, 1336 n.2 (Fed. Cir. 2007). Bad faith allegations or sham threats can support declaratory judgment when they demonstrate a real and immediate dispute. See, e.g., Hynix Semiconductor Inc. v. Rambus Inc., 527 F. Supp. 2d 1084 (N.D. Cal. 2007) (antitrust cause of action and declaratory judgment cause of action for unenforceability); TruePosition, Inc. v. Allen Telecom, Inc., No. C.A. 01-823 GMS, 2003 WL 151227 (D. Del. Jan. 21, 2003) at *5, *7; Intel Corp. v. Via Techs., Inc., No. C 99-03062 WHA, 2001 WL 777085, (N.D. Cal. Mar. 20, 2001) at *4 (describing as “counterfeit logic” Intel’s argument that Via’s declaratory judgment for non-infringement negated Via’s antitrust cause of action for sham OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 16 of 19 To the extent that these facts are not pled in the Second Amended Complaint, the Court should grant leave for Jacobsen to amend his Complaint. In Micron, declaratory defendant MOSAID sent demand letters to declaratory plaintiff Micron, one of its major competitors, in 2001 and 2002. MOSAID then began suing other major competitors, Samsung Electronics Company Ltd., Hynix Semiconductor Inc., and Infineon Technologies of North America. Id. at 899-900. In 2006, Micron filed a declaratory judgment action in the Northern District of California, choosing 14 MOSAID patents as a part of the suit. Id. at 900. A number of these patents had issued after MOSAID’s last demand letter in 2001. Request for Judicial Notice, Ex. H ¶¶ 15, 40. The following day, MOSAID filed a patent infringement lawsuit against Micron in Texas. Micron, 518 F.3d at 900. Using pre-MedImmune law, the district court in the Northern District of California dismissed Micron’s declaratory judgment suit for lack of jurisdiction. Id. at 900. The Federal Circuit reversed. Id. at 901-02. The Federal Circuit said MOSAID’s pattern of litigation against its competitors, and MOSAID’s statements that it intended to enforce its patents aggressively, were sufficient for the district court to have jurisdiction over Micron’s declaratory judgment complaint. Id. at 900-02. A similar pattern exists here. Defendants obtained their patents and aggressively seek to enforce them. Defendants obtained a number of patents related to model train controls systems technology. SAC App. A. They boast that they own key patents in the model train control system software industry, and that manufacturers and an open source group copied the technology in Defendants’ patents. See Jacobsen Decl. Ex. K at 2. JMRI is the only open source group offering model train control systems software. Thus Defendants had directed their allegations of Like MOSAID in Micron, Defendants have a history of suing their major competitors, DigiToys and Freiwald Software, and Freiwald Software’s distributors. Request for Judicial Notice Exs. I & J. They boast about these lawsuits on their website. Jacobsen Decl. Ex. L at 4. The lawsuits against DigiToys and Freiwald Software asserted all 342 claims of all Katzer patents that had issued when the lawsuits were filed, Sept. 17, 2002, even though Defendants in their Sept. 18, 2002 demand letter alleged infringement of only two claims from two patents and stated possible OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 17 of 19 infringement of selected claims of another patent. SAC App. A; Request for Judicial Notice Exs. I, J, K, & L. Defendants menaced at least one other model railroader, Glenn Butcher, through a threat of bringing a patent infringement lawsuit, SAC ¶ 374; Jacobsen Decl. Ex. J. Then Defendants and their patent attorney, Kevin Russell, sent multiple demand letters to Jacobsen’s home and stated in their FOIA request to the U.S. Department of Energy that Jacobsen infringed multiple patents. SAC ¶¶ 377-383; Jacobsen Decl. Exs. A, C, D, E at 1, & G. Defendants have represented the same to this Court. In their initial letters, Defendants focused on claim 1 of the ‘329 patent, and offered a license for $19/copy. Jacobsen Decl. Ex. A. In later letters, Defendants stated they were investigating whether Jacobsen infringed other patents. Id. Ex. C. They increased the license fee to $29/copy. Id. This 50 percent increase in license fee suggests that Defendants had found other patents that they were going to assert Jacobsen infringed. Also, because all patents, except U.S. Patent No. 6,065,406, have terminal disclaimers, they are closely related in scope. Infringing one claim of one patent could mean infringing one or more claims of multiple patents. Furthermore, Defendants previously had identified only two claims from 2 patents that they asserted DigiToys and Freiwald infringed, but sued DigiToys and Freiwald for infringement of 342 claims in 3 patents. Request for Judicial Notice Exs. I, J, K, & L. Thus, Jacobsen would have reason to believe that Defendants would assert a massive number of claims against him, although pre-MedImmune law would not have permitted Jacobsen to seek declaratory judgment on them in March 2006. Meanwhile, as a result of Defendants’ tactics, DigiToys went out of business in March 2008, leaving Jacobsen and JMRI as Defendants’ only major U.S.-based competitor—and Defendants’ only remaining target. A court looks to the totality of the circumstances to determine if declaratory judgment jurisdiction exists. Plumtree Software, Inc. v. Datamize, LLC, 473 F.3d 1152, 1159 (Fed. Cir. 2006). Given the circumstances, the situation is almost exactly the same as in Micron. Because the Micron district court had jurisdiction over Micron’s declaratory judgment complaint, the district court here in Jacobsen has jurisdiction over declaratory judgment causes of action of non- infringement, invalidity, and unenforceability of all issued Katzer patents. OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 18 of 19 Court Should Retain Jurisdiction to Hear Motion for Attorneys Fees
Because Jacobsen is the Prevailing Party

Because Defendants’ disclaimer was not a purely voluntary and private act done outside the context of litigation, Jacobsen is, and should be, deemed the prevailing party. To prevail, a party must achieve a material alteration of the legal relationship between the parties, and that alteration must be judicially sanctioned. Carbonell v. I.N.S., 429 F.3d 894, 898 (9th Cir. 2005). There’s no question that Jacobsen obtained a material alteration of the legal relationship. A judgment against a party qualifies as a judicially sanctioned alteration, as does a consent decree, Buckhannon Board & Care Home, Inc. v. West Virginia Dep’t of Health & Human Resources, 532 U.S. 598, 604 (2001), but a party may still prevail without achieving either a judgment or obtaining a consent decree if the change has the necessary judicial imprimatur. Buckhannon, 532 U.S. at 605; Highway Equipment Co. v. FECO, Ltd., 469 F.3d 1027, 1034-36 (Fed. Cir. 2006); Inland Steel Co. v. LTV Steel Co., 364 F.3d 1318, 1320 (Fed. Cir. 2004); Samsung Elecs. Co. v. Rambus Inc., 440 F. Supp. 2d 495, 503-05 (E.D. Va. 2006). However, a party is not deemed as having prevailed if the change in the parties’ relationship is brought about by purely voluntary and private action. See Buckhannon, 532 U.S. at 604 n.7, 605. Defendants did not voluntarily file the statutory disclaimer. Defendants were subject to a Jan. 23, 2008 order from Judge Laporte to provide, by Jan. 31, 2008, disclosures relating to their positions on infringement, validity, and enforceability of the ‘329 patent. Order [Docket #199] at 1. They failed to provide those disclosures. To avoid sanctions and a contempt order from having violated Judge Laporte’s order, Defendants did not merely covenant not to sue on the ‘329 patent, but took the draconian step of filing a statutory disclaimer, destroying not only their rights in claim 1, but all 27 claims in the ‘329 patent. Given the deadlines that Defendants faced, this action, which changed the relationship between the parties, cannot be called voluntary, and it was brought The change in the parties’ relationship has the necessary judicial imprimatur. As the docket reflects, Judge Laporte ordered the disclosures. She did not impose sanctions for Defendants’ violation of her court order. She accepted this disclaimer in lieu of the disclosures. These actions OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS Case 3:06-cv-01905-JSW Document 243 Filed 10/10/2008 Page 19 of 19 provide the necessary judicial imprimatur to make Jacobsen the prevailing party. Also, Defendants conceded that Jacobsen has obtained all the relief that he sought relating to the ‘329 patent. Opp. to Plaintiff’s Mot. for Early Discovery at 4. If Defendants and Kevin Russell also stipulate to vacate the anti-SLAPP ruling, Jacobsen is willing to stipulate to this regarding noninfringement, invalidity, and unenforceability of the ‘329 patent, and asks the Court to make this stipulation a part of its order. This would also give the change in the relationship between the parties the necessary judicial imprimatur to make Jacobsen the prevailing party. For these reasons, this Court should deem Jacobsen the prevailing party, and permit Jacobsen to seek attorneys’ fees under 35 U.S.C. Sec. 285. This forms yet another basis for the Court to retain jurisdiction. CONCLUSION
For the reasons stated above, Jacobsen asks the Court to deny Defendants’ motion to dismiss Jacobsen’s declaratory judgment causes of action relating to the ‘329 patent, and to deny their motion to strike various relief associated with that cause of action. Jacobsen asks the Court for leave to amend so that Jacobsen may include other Katzer patents in his declaratory judgments actions for noninfringement, invalidity, and unenforceability, per Micron. Finally, Jacobsen asks the Court to deem him the prevailing party of the patent declaratory judgment causes of action. Victoria K. Hall, Esq. (SBN 240702) LAW OFFICE OF VICTORIA K. HALL 3 Bethesda Metro Suite 700 Bethesda MD 20814 8 Jacobsen may also be entitled to seek sanctions for Defendants’ unreasonable 2-year delay in filing this disclaimer. Jacobsen prefers, as a matter of practice, to avoid sanctions motions. Addressing the attorney fee award issue under 35 U.S.C. Sec. 285 will likely make it unnecessary OPPOSITION TO DEFENDANTS’ MATTHEW KATZER AND KAMIND ASSOCIATES, INC.’S MOTION TO DISMISS FOR MOOTNESS

Source: http://jmri.sourceforge.net/k/docket/243.pdf

Clomid serophene

S o u t h M i a m i O B - G Y N A s s o c i a t e s H elp fu l Res ou rces This fact sheet is meant to provide you with basic information about this medicine. As usual, any further questions should be discussed with your doctor or p 1. What is Serophene/Clomid? It is the brand name for Clomiphene citrate, which is a medicine that has been on the market since the 1960s and introd

Medical news_ asco breast_ implants may quell hormone deficiency - printable version

ASCO Breast: Implants May Quell Hormone Deficiency By Charles Bankhead, Staff Writer, MedPage Today Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. October 04, 2010 MedPage Today Action Points Note that this study was published as an abstract and presented at aconference. These data and conclusions should be considered

Copyright © 2010-2018 Pharmacy Drugs Pdf